Overexpression of Lipocalin 2 leads to the resistance of CRC to 5-FU by inhibiting ferroptosis in vitro and in vivo, which is attributed to the reduction in intracellular iron levels and upregulation of GPX4 and xCT. The gene discussed is LCN2; the disease is colorectal carcinoma.